トポイソメラーゼ阻害薬
Bioorg. Med. Chem. 17 (20): 7145–55. (Oct 2009). doi:10.1016/j.bmc.2009.08.066. PMC 2769207. PMID 19783447. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769207/.
“The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode”. Bioorg. Med. Chem. 18 (15): 5535–52. (Aug 2010). doi:10.1016/j.bmc.2010.06.040. PMC 2911012. PMID 20630766. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911012/.
“Design, synthesis, and biological evaluation of 14-substituted aromathecins as Topoisomerase I inhibitors”. J. Med. Chem. 51 (15): 4609–19. (Aug 2008). doi:10.1021/jm800259e. PMC 2538619. PMID 18630891.